Excerpt: A new study published in The Journal of Risk & Insurance explores the financial implications of banning insurance companies from accessing genetic information. Drawing on data that includes economic, demographic, and relevant family background information, the study simulates the market for 10-year life insurance plans that include breast cancer testing for women 35-39 years of age, examining the potential impact of keeping genetic test results away from insurers.  MORE >>